Multi-omics analysis of an immune-based prognostic predictor in non-small cell lung cancer

BACKGROUND: Inhibitors targeting immune checkpoints, such as PD-1/PD-L1 and CTLA-4, have prolonged survival in small groups of non-small cell lung cancer (NSCLC) patients, but biomarkers predictive of the response to the immune checkpoint inhibitors (ICIs) remain rare. METHODS: The nonnegative matri...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Yang, Tang, Lili, Liu, Ziling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8662860/
https://www.ncbi.nlm.nih.gov/pubmed/34893051
http://dx.doi.org/10.1186/s12885-021-09044-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8662860/
https://www.ncbi.nlm.nih.gov/pubmed/34893051
http://dx.doi.org/10.1186/s12885-021-09044-4

Ejemplares similares